[go: up one dir, main page]

MXPA03006648A - Compuestos antitombroticos, su preparacion y su utilizacion como medicamentos. - Google Patents

Compuestos antitombroticos, su preparacion y su utilizacion como medicamentos.

Info

Publication number
MXPA03006648A
MXPA03006648A MXPA03006648A MXPA03006648A MXPA03006648A MX PA03006648 A MXPA03006648 A MX PA03006648A MX PA03006648 A MXPA03006648 A MX PA03006648A MX PA03006648 A MXPA03006648 A MX PA03006648A MX PA03006648 A MXPA03006648 A MX PA03006648A
Authority
MX
Mexico
Prior art keywords
medicaments
production
thrombotic compounds
thrombotic
compounds
Prior art date
Application number
MXPA03006648A
Other languages
English (en)
Inventor
Priepke Henning
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10104597A external-priority patent/DE10104597A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA03006648A publication Critical patent/MXPA03006648A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MXPA03006648A 2001-02-02 2002-01-26 Compuestos antitombroticos, su preparacion y su utilizacion como medicamentos. MXPA03006648A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10104597A DE10104597A1 (de) 2001-02-02 2001-02-02 Antithrombotische Verbindungen, deren Herstellung und deren Verwendung als Arzneimittel
DE10135435 2001-07-26
PCT/EP2002/000823 WO2002062778A2 (de) 2001-02-02 2002-01-26 Antithrombotische verbindungen, deren herstellung und deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
MXPA03006648A true MXPA03006648A (es) 2003-10-15

Family

ID=26008392

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03006648A MXPA03006648A (es) 2001-02-02 2002-01-26 Compuestos antitombroticos, su preparacion y su utilizacion como medicamentos.

Country Status (5)

Country Link
EP (1) EP1390357A2 (es)
JP (1) JP2004522759A (es)
CA (1) CA2435492A1 (es)
MX (1) MXPA03006648A (es)
WO (1) WO2002062778A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
DE10234058A1 (de) * 2002-07-26 2004-02-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Benzoesäureamide, deren Herstellung und deren Verwendung als Arzneimittel
EP1546089A2 (en) * 2002-08-09 2005-06-29 TransTech Pharma Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
US7247654B2 (en) 2003-06-04 2007-07-24 Bristol-Myers Squibb Company 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors
US7570259B2 (en) 2004-06-01 2009-08-04 Intel Corporation System to manage display power consumption
JP2008512364A (ja) * 2004-09-06 2008-04-24 エフ．ホフマン−ラ ロシュ アーゲー ４−アミノメチルベンズアミジン誘導体及び第ＶＩＩａ因子阻害剤としてのその使用
US7576098B2 (en) 2004-12-08 2009-08-18 Bristol-Myers Squibb Company Heterocyclic compounds as inhibitors of factor VIIa
CN101466676B (zh) 2006-04-12 2012-07-18 默沙东公司 吡啶基酰胺类t-型钙通道拮抗剂
CA2701594C (en) 2007-10-24 2014-02-18 Merck Sharp & Dohme Corp. Heterocycle phenyl amide t-type calcium channel antagonists
MX388871B (es) 2014-06-27 2025-03-20 Nogra Pharma Ltd Moduladores del receptor arilo y metodos para elaborar y usar los mismos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD142804A3 (de) * 1977-11-07 1980-07-16 Wagner Guenter Verfahren zur herstellung von na-alkyl-bzw.na-aryl-sulfonylierten omega-amidinophenyl-alpha-aminoalkylcarbonsaeureamiden
EP0654465A1 (de) * 1993-11-15 1995-05-24 Ciba-Geigy Ag Polyaminopolyamide
US5741819A (en) * 1995-06-07 1998-04-21 3-Dimensional Pharmaceuticals, Inc. Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
WO2000056707A1 (en) * 1999-03-24 2000-09-28 Sepracor, Inc. Diaryl thioethers, compositions and uses thereof
EP1206446B1 (de) * 1999-08-07 2004-05-26 Boehringer Ingelheim Pharma GmbH & Co.KG Carbonsäureamide, deren herstellung und deren verwendung als arzneimittel
DE10033337A1 (de) * 2000-07-08 2002-01-17 Boehringer Ingelheim Pharma Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
WO2002062778A2 (de) 2002-08-15
CA2435492A1 (en) 2002-08-15
WO2002062778A3 (de) 2003-12-11
JP2004522759A (ja) 2004-07-29
EP1390357A2 (de) 2004-02-25

Similar Documents

Publication Publication Date Title
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
AU2003293757A1 (en) Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
HUP0401293A3 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
DE60223699D1 (en) Diarylsulfidderivat, dessen additionssalz und immunsuppressivum
AU2002337047A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
MXPA03007349A (es) Derivados de xantina, su preparacion y su empleo como medicamentos.
IL159120A0 (en) Cdk inhibiting pyrimidines, production thereof and their use as medicaments
AU2002312933A1 (en) CDK inhibiting pyrimidines, production thereof and their use as medicaments
HUP0401648A3 (en) 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same
ZA200305498B (en) Xanthine derivative, production and use thereof as a medicament.
PT2206702E (pt) Composto bicíclico, sua produção e utilização
HUP0401329A2 (hu) Aminoalkil-helyettesített aromás kétgyűrűs vegyületek, eljárások előállításukra és alkalmazásuk gyógyszerekként
ZA200500877B (en) Antimicrobial aza-bicyclic derivatives, their compositions and uses.
IL164442A0 (en) Benzoxazinone-derived compounds, their preparationand use as medicaments
MXPA03008630A (es) Derivados de arilisoxazolinas, procedimientos para su preparacion y su utilizacion como agentes plaguicidas.
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
PL376399A1 (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
ZA200501431B (en) 5-Aryltetrazole compounds, compositions thereof, and uses therefor.
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
IL175245A0 (en) Thiozolidinones, production and use thereof as medicaments
MXPA03009002A (es) 5-halogeno-6-fenil-7-fluoroalquilamino-triazolopirimidinas.
MXPA03006648A (es) Compuestos antitombroticos, su preparacion y su utilizacion como medicamentos.
MXPA03008186A (es) Amidas de acidos carboxilicos antitromboticas, su preparacion y su uso como medicamentos.
ZA200400092B (en) Product manufacturing line.
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament